“…In the last two decades, much effort has been devoted to finding non-invasive methods of predicting the presence of EVs and HREVs. Currently, non-invasive predictive parameters are predominantly imaging/ultrasonographic and laboratory parameters, including spleen diameter, spleen/liver stiffness, portal/splenic vein diameter, platelet count, platelet count to spleen diameter ratio, Fibrosis-4 score (FIB-4), aspartate aminotransferase to platelet ratio index (APRI), and aspartate aminotransferase to alanine aminotransferase ratio (AAR) (Giannini et al, 2003;Giannini et al, 2006;Hong et al, 2009;Kim et al, 2010;Colecchia et al, 2012;Berzigotti et al, 2013;Montasser et al, 2014;Morishita et al, 2014;Rockey et al, 2016). A few studies have reported the non-invasive prediction of EVB (Kothari et al, 2019;Wan et al, 2021) and large EVs (Sharma and Aggarwal, 2007;Lijing et al, 2014).…”